Author:
Sun Da-lin,Guo Zi-yi,Liu Wen-yuan,Zhang Lin,Zhang Zi-yuan,Hu Ya-ling,Li Su-fen,Zhang Ming-yu,Zhang Guang,Wang Jin-jing,Fang Jing-ai
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Lindblom R, Higgins G, Coughlan M, de Haan JB. Targeting mitochondria and reactive oxygen species-driven pathogenesis in diabetic nephropathy. Rev Diabet Stud 2015;12:134–156.
2. Duan J, Duan G, Wang C. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central chinese urban population: a cross-sectional survey. BMC Nephrol 2020;21:115.
3. Ao L, Xie Y. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease. J Central South Univer Med Sci (Chin) 2021;46:1403–1408.
4. Liu J, Sun M, Xia Y. Phloretin ameliorates diabetic nephropathy by inhibiting nephrin and podocin reduction through a non-hypoglycemic effect. Food Funct 2022;13:6613–6622.
5. Morito N, Yoh K, Ojima M, Okamura M, Nakamura M, Hamada M, et al. Overexpression of mafb in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 2014;25:2546–2557.